prof. MUDr. Jaroslav Štěrba, Ph.D.
Vice-Dean for Professional Education, Faculty of Medicine
Correspondence Address:
Černopolní 212/9, 662 63 Brno
Phone: | +420 532 23 4600, 4614 |
---|---|
E‑mail: |
Total number of publications: 468
2016
-
Non-DHFR-mediated effects of methotrexate in osteosarcoma cell lines: epigenetic alterations and enhanced cell differentiation
Cancer Cell International, year: 2016, volume: 16, edition: 14, DOI
-
Objective response to vemurafenib in a child treated for metastatic desmoplastic infantile
Year: 2016, type: Conference abstract
-
Pre-treatment VD levels and VDR receptors as potential predictors of occurrence and overall survival in paediatric patients with solid tumours-a single institution pilot study
Tumor Biology, year: 2016, volume: 37, edition: 7, DOI
-
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis
Lancet Oncology, year: 2016, volume: 17, edition: 4, DOI
-
Quantitative proteomic profiling in medulloblastoma recapitulates subgrouping based on transcriptional profiles
Year: 2016, type: Conference abstract
-
Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis
Journal of Clinical Oncology, year: 2016, volume: 34, edition: 21, DOI
2015
-
Atypical nuclear localization of CD133 plasma membrane glycoprotein in rhabdomyosarcoma cell lines
International Journal of Molecular Medicine, year: 2015, volume: 36, edition: 1, DOI
-
B-Cell Activating Factor as a Cancer Biomarker and Its Implications in Cancer-Related Cachexia
Biomed Research International, year: 2015, volume: 2015, edition: "792187", DOI
-
Capizzi methotrexate with BFM backbone without craniospinal irradiation is effective treatment for pediatric lymphoblastic lymphoma: results from 5 countries with I-BFM LL 09 protocol
Year: 2015, type: Conference abstract
-
DHFR-mediated effects of methotrexate in medulloblastoma and osteosarcoma cells: The same outcome of treatment with different doses in sensitive cell lines
Oncology Reports, year: 2015, volume: 33, edition: 5, DOI